Treatment-related neuroendocrine prostate cancer managed with partial stereotactic ablative radiotherapy (P-SABR) for long-term survival: a case series.
Transl Androl Urol
; 12(1): 128-138, 2023 Jan 30.
Article
in En
| MEDLINE
| ID: mdl-36760876
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Transl Androl Urol
Year:
2023
Document type:
Article
Affiliation country: